Title: September 16, 2026, Peptides Now! - Epitalon vs Epithalon - Deep Dive with Alex and Jessica

Keep the momentum at: https://www.v2u.us/subscribe

If you’ve found this episode informative, insightful or beneficial, don’t forget to like and share with someone who may also benefit.

Primary Keyword Cluster: Epitalon, Epithalon, Peptide Therapy, Telomere Lengthening, FDA PCAC 2026

Description: In this episode of Peptides Now!, hosts Alex and Jessica conduct a deep dive into the science, history, and 2026 regulatory landscape surrounding Epitalon and Epithalon. Discover how this pineal-derived tetrapeptide evolved from a Soviet Cold War military research project into a central focus of modern cellular longevity and federal compounding debates. Learn about the crucial differences between crude animal extracts and synthetic isolates, the genomic mechanisms behind telomerase activation, and what the July 2026 FDA advisory committee vote means for providers and patients.

• Cold War Origins and Nomenclatural Equivalence: Alex and Jessica clarify the common confusion between Epithalamin and Epitalon, tracing the tetrapeptide AEDG back to Soviet-era bioregulation research and explaining how synthetic isolates eliminate crude extract variability.

• Genomic Mechanisms and Telomere Biology: Explore how Epitalon functions as a low molecular weight transcription factor that enters the cell nucleus to upregulate telomerase activity and extend telomeres, backed by landmark 2025 Western replication studies.

• July 2026 FDA PCAC Review and Safety Profile: An in-depth analysis of the FDA Pharmacy Compounding Advisory Committee's 7–5 vote on Epitalon, the critical dosing shift from milligrams to micrograms, and theoretical oncogenic safety considerations.

Timestamps:
• 0:00 – Introduction to Epitalon and Cold War Bioregulator Origins
• 3:15 – Epithalamin vs Epitalon — Clearing Up Nomenclature Confusion
• 6:45 – Molecular Mechanisms — DNA Binding and Telomerase Activation
• 10:50 – 2025 Western Replications and Pineal Melatonin Restoration
• 14:20 – Dosing Translation Errors — Milligrams vs Microgram Protocols
• 18:00 – July 24, 2026 FDA PCAC Review and Section 503A Advisory Vote
• 21:00 – Safety Profile, Oncogenic Risks, and Final Environmental Biohacks

Don't miss our next episode, where we'll continue to unravel the latest in AI innovation and market trends.

Tags and Keywords: #Epitalon, #Epithalon, #PeptidesNow, #Peptides, #Telomeres, #FDAPCAC2026, #Longevity, #AntiAging